EP Patent

EP3528807A4 — Methods of treating developmental disorders and/or seizure disorders with flupirtine

Assigned to Ovid Therapeutics Inc · Expires 2020-06-17 · 6y expired

What this patent protects

Patent listed against fenfluramine-hydrochloride.

Drugs covered by this patent

fenfluramine-hydrochloride (FENFLURAMINE HYDROCHLORIDE)

Patent Metadata

Patent number: EP3528807A4
Jurisdiction: EP
Classification: —
Expires: 2020-06-17
Drug substance claim: No
Drug product claim: No
Assignee: Ovid Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.